Genetic factors also play a significant role, with variations in apolipoprotein E (ApoE) and mutations in the amyloid precursor protein (APP) and presenilin genes (PS1 and PS2) linked to a heightened risk of AD [13,14,15]. This evidence concerns the gene APOE and Alzheimer disease.